Read publication

In 2014, the Food and Drug Administration (FDA) issued a regulation saying that any companies that wished to import health products under the FDA controls must obtain a License Per Invoice (LPI) prior to their arrival. An LPI was a license applied for through the FDA's e-Service for each shipment, to inform the FDA of the import of health products using the invoices. The FDA would issue an LPI as an acknowledgement and electronically forwarded it to the Customs Department as evidence for customs formalities.

Explore More Insight